CTA
AMGN icon

Carillon Tower Advisers’s Amgen AMGN Stock Holding History

Carillon Tower Advisers’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$6.58M Sell
28,600
-54,174
-65% -$12.5M 0.04% 380
2020
Q3 		$21M Buy
82,774
+166
+0.2% +$41.1K 0.28% 128
2020
Q2 		$19.5M Sell
82,608
-4,419
-5% -$1.01M 0.15% 201
2020
Q1 		$17.4M Buy
87,027
+47,827
+122% +$10.4M 0.17% 192
2019
Q4 		$9.45M Sell
39,200
-2,900
-7% -$639K 0.06% 333
2019
Q3 		$8.15M Sell
42,100
-100
-0.2% -$19.2K 0.06% 352
2019
Q2 		$7.78M Sell
42,200
-1,400
-3% -$251K 0.05% 356
2019
Q1 		$8.28M Buy
43,600
+2,300
+6% +$439K 0.06% 350
2018
Q4 		$8.04M Buy
+41,300
New +$8.06M 0.07% 325
2018
Q3 		– Sell
-44,800
Closed -$8.27M – 425
2018
Q2 		$8.27M Buy
+44,800
New +$7.92M 0.07% 336

Other funds holding AMGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Carillon Tower Advisers's AMGN Position: Q4 2020 in Review

Carillon Tower Advisers reduced its Amgen (AMGN) stake by 65% in Q4 2020, selling an estimated $12.5M and leaving 28,600 shares worth $6.58M. The position accounts for 0.04% of the portfolio, ranked #380.

Carillon Tower Advisers first reported a position in AMGN in Q2 2018 and has held it in 10 quarters since. The position peaked at $21M in Q3 2020. 2,220 funds tracked by Wall St. Rank hold AMGN as of Q4 2020.

  • Carillon Tower Advisers held 28,600 shares of Amgen worth $6.58M as of Q4 2020.
  • Carillon Tower Advisers sold 54,174 Amgen shares in Q4 2020, an estimated $12.5M.
  • Amgen made up 0.04% of Carillon Tower Advisers's portfolio in Q4 2020, its #380 holding.
  • Carillon Tower Advisers first reported a position in Amgen in Q2 2018 and has held it in 10 quarters since.
  • Carillon Tower Advisers's Amgen position peaked at $21M in Q3 2020.
  • 2,220 funds tracked by Wall St. Rank held Amgen as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.